News & Events

Media Coverage

KemPharm tackles pediatric ADHD using ligand-activated drug
Drug Delivery Business News
9/14/2017
The Prodrug Opportunity: Making Good Drugs Better
Genetic Engineering & Biotechnology News (GEN)
7/19/2017
Interview – Travis Mickle discusses Kempharm's prodrug future
EP Vantage
4/27/2017
Despite FDA Setback, KemPharm Advancing Prodrug Pipeline
The Bio Report
1/12/2017
KemPharm CEO On Recent Results, Catalysts And Prospects: 'ADHD Is By Far The Larger Market Opportunity'
Benzinga
1/12/2017

 

Media Archive »